IPF or Lung fibrosis is serious diesease.In USA, FDA recently approved OFEV, the first medicine to treat IPF. Similar medicine for such treatment was manufactured in INDIA, under the name, PIRFENIDONE and some persons who used it had severe side effect on Liver and had to discontinue for this reason.
Understand, similar medication is available in Europe under the name, ESBRIET Also understand, there is similar medication under the name, NINTEDANIB for Lung Fibrosis. All these names are confusing; can someone help clarify about these four different names or really four different medications for IPF???